Vortex Imaging Inc. Raises $12 Million and Expands Board Leadership to Advance Computational Ultrasound Solutions

Vortex Imaging Inc., a developer of advanced imaging technologies, has successfully closed a $12 million financing round aimed at accelerating the development and commercialization of its innovative computational ultrasound system. The funding was secured from a mix of existing and new investors, including 10D Ventures, Entrée Capital, Harel T.E.C Partnership, Connecticut Innovations, and PhiFund Ventures. This financing round, announced on May 18, 2026, will facilitate the company’s efforts to achieve FDA clearance and launch its product in the market.

Vortex Imaging is focused on transforming ultrasound technology by developing a compact imaging system that delivers high-quality 3D volumetric imaging directly at the point of care. Traditional imaging workflows often rely on centralized radiology suites, leading to delays in patient care. By utilizing pioneering computational image reconstruction technology and GPUs-on-Cloud, Vortex aims to standardize and streamline ultrasound imaging, making it more accessible and efficient in clinical settings. The technology promises to reduce operator dependency and variability associated with conventional ultrasound workflows while avoiding the risks of ionizing radiation.

To further bolster its strategic positioning, Vortex Imaging has expanded its board of directors to include seasoned leaders from the healthcare and medtech sectors. Ori Hadomi, former CEO of Mazor Robotics and current Vice President of Strategic Initiatives & Partnerships at Medtronic, has been appointed as Chairman of the Board. The board also features prominent figures such as Chris Cleary, former Vice President of Corporate Development at Medtronic, and Yahal Zilka, co-founder and Managing Partner at 10D Ventures. This enhanced leadership team brings extensive experience in guiding transformative medical technologies from development to commercialization.

The initial clinical focus of Vortex Imaging's technology is on urology and nephrology, with plans for broader applications across various diagnostic and procedural domains. The company's approach aims to provide physicians with advanced imaging capabilities typically associated with more complex modalities like CT and MRI, while maintaining the portability and safety advantages of ultrasound. As the healthcare industry increasingly seeks to improve access to imaging services, Vortex's innovations could play a significant role in reshaping how advanced imaging is performed in everyday clinical practice.

The successful closing of this financing round reflects a growing interest in innovative healthcare technologies that enhance patient care and streamline clinical workflows. As Vortex Imaging advances toward FDA clearance and market launch, the implications of its technology could extend beyond its initial applications, potentially influencing the broader medical imaging landscape. The combination of high-quality volumetric imaging and reduced operator dependency positions Vortex to meet the evolving needs of healthcare systems, paving the way for a more scalable and standardized approach to imaging in the future.